Publication: The case for open science: rare diseases
| dc.contributor.author | Rubinstein, Yaffa R | |
| dc.contributor.author | Robinson, Peter N | |
| dc.contributor.author | Gahl, William A | |
| dc.contributor.author | Avillach, Paul | |
| dc.contributor.author | Baynam, Gareth | |
| dc.contributor.author | Cederroth, Helene | |
| dc.contributor.author | Goodwin, Rebecca M | |
| dc.contributor.author | Groft, Stephen C | |
| dc.contributor.author | Hansson, Mats G | |
| dc.contributor.author | Harris, Nomi L | |
| dc.contributor.author | Huser, Vojtech | |
| dc.contributor.author | Mascalzoni, Deborah | |
| dc.contributor.author | McMurry, Julie A | |
| dc.contributor.author | Might, Matthew | |
| dc.contributor.author | Nellaker, Christoffer | |
| dc.contributor.author | Mons, Barend | |
| dc.contributor.author | Paltoo, Dina N | |
| dc.contributor.author | Pevsner, Jonathan | |
| dc.contributor.author | Posada De la Paz, Manuel | |
| dc.contributor.author | Rockett-Frase, Alison P | |
| dc.contributor.author | Roos, Marco | |
| dc.contributor.author | Rubinstein, Tamar B | |
| dc.contributor.author | Taruscio, Domenica | |
| dc.contributor.author | van Enckevort, Esther | |
| dc.contributor.author | Haendel, Melissa A | |
| dc.contributor.funder | National Institutes of Health (Estados Unidos) | |
| dc.contributor.funder | United States Department of Health and Human Services | |
| dc.contributor.funder | NIH - National Institute of Child Health and Human Development (NICHD) (Estados Unidos) | |
| dc.date.accessioned | 2022-08-31T08:38:05Z | |
| dc.date.available | 2022-08-31T08:38:05Z | |
| dc.date.issued | 2020-09-11 | |
| dc.description.abstract | The premise of Open Science is that research and medical management will progress faster if data and knowledge are openly shared. The value of Open Science is nowhere more important and appreciated than in the rare disease (RD) community. Research into RDs has been limited by insufficient patient data and resources, a paucity of trained disease experts, and lack of therapeutics, leading to long delays in diagnosis and treatment. These issues can be ameliorated by following the principles and practices of sharing that are intrinsic to Open Science. Here, we describe how the RD community has adopted the core pillars of Open Science, adding new initiatives to promote care and research for RD patients and, ultimately, for all of medicine. We also present recommendations that can advance Open Science more globally. | es_ES |
| dc.description.peerreviewed | Sí | es_ES |
| dc.description.sponsorship | This work was supported by the U.S. Department of Health and Human Services National Institutes of Health (5r24od011883), National Institutes of Health (NIH) Office of the Director (OD); the Monarch Initiative (1R24OD011883) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54 HD079123). | es_ES |
| dc.format.number | 3 | es_ES |
| dc.format.page | 472-486 | es_ES |
| dc.format.volume | 3 | es_ES |
| dc.identifier.citation | JAMIA Open. 2020 Sep 11;3(3):472-486. | es_ES |
| dc.identifier.doi | 10.1093/jamiaopen/ooaa030 | es_ES |
| dc.identifier.e-issn | 2574-2531 | es_ES |
| dc.identifier.journal | JAMIA Open | es_ES |
| dc.identifier.pubmedID | 33426479 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/14916 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Oxford University Press | |
| dc.relation.publisherversion | https://doi.org/10.1093/jamiaopen/ooaa030 | es_ES |
| dc.repisalud.centro | ISCIII::Instituto de Investigación de Enfermedades Raras (IIER) | es_ES |
| dc.repisalud.institucion | ISCIII | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Atribución 4.0 Internacional | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | FAIR data | es_ES |
| dc.subject | Common data elements | es_ES |
| dc.subject | Data standards | es_ES |
| dc.subject | Ontology | es_ES |
| dc.subject | Open Science | es_ES |
| dc.subject | Rare disease patients | es_ES |
| dc.title | The case for open science: rare diseases | es_ES |
| dc.type | research article | es_ES |
| dc.type.hasVersion | VoR | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | c474ba31-7f20-4966-a77e-34f9bf4f3602 | |
| relation.isAuthorOfPublication.latestForDiscovery | c474ba31-7f20-4966-a77e-34f9bf4f3602 | |
| relation.isFunderOfPublication | d863b318-3e6b-4cfc-81bb-a6d112b1f86e | |
| relation.isFunderOfPublication | 6081a0d0-d423-4510-b1af-a52eac0c92e4 | |
| relation.isFunderOfPublication | 88fb0e3d-0edd-44e0-b850-8b58f998c952 | |
| relation.isFunderOfPublication.latestForDiscovery | d863b318-3e6b-4cfc-81bb-a6d112b1f86e | |
| relation.isPublisherOfPublication | 465a0b1e-d9df-4342-b738-86ffcafc4bcf | |
| relation.isPublisherOfPublication.latestForDiscovery | 465a0b1e-d9df-4342-b738-86ffcafc4bcf |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- CaseOpenScienceRareDiseases_2020.pdf
- Size:
- 1.76 MB
- Format:
- Adobe Portable Document Format
- Description:


